Merck & Co., Inc.
(NYSE : MRK)

( )
MRK After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
0.67%143.040.7%$1166.65m
PFEPfizer Inc.
0.25%43.780.9%$917.87m
MRKMerck & Co., Inc.
1.11%85.510.6%$772.58m
BMYBristol-Myers Squibb Company
-7.40%45.691.4%$566.28m
LLYEli Lilly and Company
0.11%115.621.0%$491.60m
ABBVAbbVie, Inc.
-0.44%78.432.2%$392.45m
NVSNovartis AG Sponsored ADR
0.31%92.780.2%$181.14m
AZNAstraZeneca PLC Sponsored ADR
0.29%41.481.2%$108.12m
GSKGlaxoSmithKline plc Sponsored ADR
0.82%40.600.2%$94.96m
SNYSanofi Sponsored ADR
-0.70%43.840.2%$90.94m
NVONovo Nordisk A/S Sponsored ADR Class B
0.88%51.290.1%$77.41m
LCILannett Company, Inc.
-2.76%5.6436.6%$4.25m
AKTXAkari Therapeutics Plc Sponsored ADR
-2.34%2.091.6%$0.45m
EPIXESSA Pharma Inc
-1.30%2.270.1%$0.01m

Company Profile

Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock and companion animal species, which it sells to veterinarians, distributors, and animal producers. The Healthcare Services segment offers services and solutions that focus on engagement, health analytics, and clinical services to improve the value of care delivered to patients. The Alliances segment includes results from the Company's relationship with AstraZeneca LP related to sales of Nexium and Prilosec. The company was founded in 1891 and is headquartered in Kenilworth, NJ.